Dr. Nikhil Vivek Ambulgekar, MD

Dr. Ambulgekar practices at Henry Ford Physician Partners in Clinton Twp, Michigan.

Dr. Ambulgekar's NPI, 1497074264, was assigned on May 19, 2010. Dr. Ambulgekar holds Michigan license 4301096087.

Dr. Ambulgekar's primary practice is Henry Ford Physician Partners, at 15500 19 Mile Rd, Clinton Twp, MI 48038 in Macomb County. The practice phone is (586) 468-1600.

Dr. Ambulgekar's primary practice is Henry Ford Physician Partners in Clinton Twp, Michigan. Dr. Ambulgekar is also affiliated with Henry Ford Macomb Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Ambulgekar to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ambulgekar practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ambulgekar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Ambulgekar is licensed in Michigan.

CMS data shows 2,686 Medicare services from Dr. Ambulgekar across 20 procedure codes in 2024, for 1,097 Medicare patients. Medicare paid $137,840 for them.

CMS counts 1,097 Medicare patients who saw Dr. Ambulgekar in 2024. The largest group is 75 to 84, with 389 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ambulgekar's median patient age at 72, with 48% women.

In 2024, Dr. Ambulgekar wrote 3,312 Medicare Part D claims for 508 patients. 79% of them were for generic drugs. CMS names the drug for 3,191 of them, across 39 drugs with 11 or more claims each, at $792,179 in total drug cost. In 2023, CMS named 2,821 claims across 35 drugs.

Dr. Ambulgekar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of coronary angioplasty and stenting by Dr. Ambulgekar, more than 72% of the clinicians it reports for that procedure.

CMS Open Payments shows 384 general payments to Dr. Ambulgekar from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Abbott Laboratories paid the most, $5,698.